ATE358474T1 - Halogenhaltige zusammensetzung, verfahren zu deren herstellung und deren verwendung - Google Patents

Halogenhaltige zusammensetzung, verfahren zu deren herstellung und deren verwendung

Info

Publication number: ATE358474T1
Authority: AT; Austria
Prior art keywords: halopohalite; sodium; taurine; halogen; production
Prior art date: 2001-01-23

Application number

AT02711967T

Other languages

English (en)

Inventor

Arnaud Mainnemare

Original Assignee

Arnaud Mainnemare

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-23

Filing date

2002-01-16

Publication date

2007-04-15

2002-01-16 Application filed by Arnaud Mainnemare filed Critical Arnaud Mainnemare

2007-04-15 Application granted granted Critical

2007-04-15 Publication of ATE358474T1 publication Critical patent/ATE358474T1/de

Links

XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical class NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 abstract 3
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 2
241001465754 Metazoa Species 0.000 abstract 2
201000001245 periodontitis Diseases 0.000 abstract 2
239000011734 sodium Substances 0.000 abstract 2
229910052708 sodium Inorganic materials 0.000 abstract 2
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
201000009329 acute pericementitis Diseases 0.000 abstract 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
229910052794 bromium Inorganic materials 0.000 abstract 1
229910052801 chlorine Inorganic materials 0.000 abstract 1
239000000460 chlorine Substances 0.000 abstract 1
230000001684 chronic effect Effects 0.000 abstract 1
208000001277 chronic periodontitis Diseases 0.000 abstract 1
229910052731 fluorine Inorganic materials 0.000 abstract 1
239000011737 fluorine Substances 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
230000035876 healing Effects 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 abstract 1
230000003902 lesion Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000004936 stimulating effect Effects 0.000 abstract 1
229960003080 taurine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Virology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Molecular Biology (AREA)
Rheumatology (AREA)
Biotechnology (AREA)
Tropical Medicine & Parasitology (AREA)
Dermatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Compositions Of Macromolecular Compounds (AREA)
Glass Compositions (AREA)

AT02711967T 2001-01-23 2002-01-16 Halogenhaltige zusammensetzung, verfahren zu deren herstellung und deren verwendung ATE358474T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0100862A FR2819723B1 (fr)	2001-01-23	2001-01-23	Composition halogene, son procede de preparation et ses utilisations

Publications (1)

Publication Number	Publication Date
ATE358474T1 true ATE358474T1 (de)	2007-04-15

Family

ID=8859119

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02711967T ATE358474T1 (de)	2001-01-23	2002-01-16	Halogenhaltige zusammensetzung, verfahren zu deren herstellung und deren verwendung

Country Status (13)

Country	Link
US (3)	US20040022871A1 (de)
EP (1)	EP1401422B1 (de)
JP (3)	JP2004519462A (de)
AT (1)	ATE358474T1 (de)
AU (1)	AU2002231889A1 (de)
CA (1)	CA2435419C (de)
CY (1)	CY1106704T1 (de)
DE (1)	DE60219314T2 (de)
DK (1)	DK1401422T3 (de)
ES (1)	ES2284837T3 (de)
FR (1)	FR2819723B1 (de)
PT (1)	PT1401422E (de)
WO (1)	WO2002058692A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2819723B1 (fr) *	2001-01-23	2006-11-17	Arnaud Mainnemare	Composition halogene, son procede de preparation et ses utilisations
SE0103766D0 (sv) *	2001-11-09	2001-11-09	Astrazeneca Ab	Novel assay
AR039385A1 (es) *	2002-04-19	2005-02-16	Astrazeneca Ab	Derivados de tioxantina como inhibidores de la mieloperoxidasa
EP2725008A1 (de)	2003-08-18	2014-04-30	NovaBay Pharmaceuticals, Inc.	N,N-dihalogenierte Aminosäuren und Derivate
SE0302756D0 (sv) *	2003-10-17	2003-10-17	Astrazeneca Ab	Novel Compounds
SE0402591D0 (sv) *	2004-10-25	2004-10-25	Astrazeneca Ab	Novel use
MY140748A (en)	2004-12-06	2010-01-15	Astrazeneca Ab	Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
TWI386201B (zh) *	2005-01-25	2013-02-21	Novabay Pharmaceuticals Inc	Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法
CA2624677A1 (en) *	2005-10-06	2007-04-19	Novacal Pharmaceuticals, Inc.	System and method for the prevention of bacterial and fungal infections including urinary tract infections (uti) using n-halogenated amino acids
TW200804383A (en) *	2006-06-05	2008-01-16	Astrazeneca Ab	New compounds
EP2120555A1 (de) *	2007-01-31	2009-11-25	Adam Heller	Verfahren und zusammensetzungen zur schmerzbehandlung
US20110151025A1 (en) *	2008-04-10	2011-06-23	Novabay Pharmaceuticals, Inc.	Compositions Comprising N-Halogenated or N,N-Dihalogenated Amine for Treatment and Prophylaxis of Bronchopulmonary Infections
WO2009127924A1 (en) *	2008-04-15	2009-10-22	Waldemar Gottardi	Compositions and devices for antisepsis and anticoagulation
US8945540B2 (en) *	2008-05-09	2015-02-03	Exoxemis, Inc.	Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof
JP5952899B2 (ja)	2011-06-15	2016-07-13	アルエルエスグローバルアーベー	う蝕象牙質組織の検出と除去
SE536581C2 (sv)	2012-07-24	2014-03-11	Rls Global Ab	Ett kit för behandling av sår eller liknande och ett preparat och metoder därav
EP2950777B1 (de) *	2013-01-30	2021-06-23	Straumann Holding AG	Zahnfleischerkrankungsbehandlung
FR3009196B1 (fr) *	2013-08-02	2015-10-02	Arnaud Mainnemare	Nouvelle composition pour le traitement de l'inflammation
ES2907961T3 (es)	2016-06-09	2022-04-27	De Nora Holdings Us Inc	Producción electrolítica de soluciones de cloramina orgánica
RU2624166C1 (ru) *	2016-07-29	2017-06-30	Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО КубГМУ Минздрава России)	Способ лечения деструктивных форм хронических верхушечных периодонтитов
LU101842B1 (en)	2020-06-08	2021-12-08	Arnaud Mainnemare	Pharmaceutical Composition for treating or preventing lesions and infections in a mammal
IT202000028082A1 (it)	2020-11-23	2022-05-23	Md Italy Srl	Composizione, preparazione ed impiego di una miscela a base di bromo per l’igiene perioculare, il trattamento e la prevenzione delle blefariti

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4012842A (en) *	1972-06-12	1977-03-22	National Patent Development Corporation	Dental treatment method and apparatus
CA1025705A (en)	1972-06-12	1978-02-07	Jaroslav Vit	Method and apparatus for removal of dental plaque and caries by means of high velocity pulsating jet of liquid
US3998945A (en) *	1972-06-12	1976-12-21	National Patent Development Corporation	Dental treatment
US4035483A (en) *	1973-05-29	1977-07-12	John Bunyan	Antiseptic and non-toxic substance and a method of making the same
DE4041703C2 (de) *	1990-12-24	1993-10-21	Waldemar Dr Gottardi	Alkalimetallsalze des N-Chlortaurins in kristalliner Form, Verfahren zu deren Herstellung und deren Verwendung
JP3759757B2 (ja) *	1994-01-13	2006-03-29	相互薬工株式会社	殺菌剤
DE19712565A1 (de) *	1997-03-25	1998-10-01	Thomas W Dr Stief	Arzneimittel auf der Basis eines Singulett-Sauerstoff erzeugenden Agenzes
JPH11279057A (ja)	1998-03-30	1999-10-12	Arimasa Miyamoto	ＮＦκＢ活性化阻害剤
DE19816102C1 (de) *	1998-04-10	1999-09-16	Waldemar Gottardi	Verfahren zum Inaktivieren von Viren in Proteinlösungen, Verwendung von N-Chlortaurin in dem Verfahren sowie nach dem Verfahren hergestellte Proteinlösungen
EP1183058B1 (de) *	1999-06-04	2008-01-02	Oxibio, Inc.	Infektionsmittel enthaltendes medizinisches gerät und verfahren zu ihrer darstellung
FR2819723B1 (fr) *	2001-01-23	2006-11-17	Arnaud Mainnemare	Composition halogene, son procede de preparation et ses utilisations
JP4948846B2 (ja)	2006-02-08	2012-06-06	株式会社東芝	突入電流抑制回路を備えた電源装置

2001
- 2001-01-23 FR FR0100862A patent/FR2819723B1/fr not_active Expired - Lifetime
2002
- 2002-01-16 PT PT02711967T patent/PT1401422E/pt unknown
- 2002-01-16 AU AU2002231889A patent/AU2002231889A1/en not_active Abandoned
- 2002-01-16 DK DK02711967T patent/DK1401422T3/da active
- 2002-01-16 CA CA2435419A patent/CA2435419C/fr not_active Expired - Lifetime
- 2002-01-16 DE DE60219314T patent/DE60219314T2/de not_active Expired - Lifetime
- 2002-01-16 WO PCT/FR2002/000151 patent/WO2002058692A2/fr not_active Ceased
- 2002-01-16 JP JP2002559026A patent/JP2004519462A/ja active Pending
- 2002-01-16 AT AT02711967T patent/ATE358474T1/de active
- 2002-01-16 EP EP02711967A patent/EP1401422B1/de not_active Expired - Lifetime
- 2002-01-16 ES ES02711967T patent/ES2284837T3/es not_active Expired - Lifetime
2003
- 2003-07-18 US US10/622,262 patent/US20040022871A1/en not_active Abandoned
2007
- 2007-07-04 CY CY20071100893T patent/CY1106704T1/el unknown
2008
- 2008-09-24 US US12/236,613 patent/US7879366B2/en not_active Expired - Fee Related
2010
- 2010-05-21 JP JP2010117839A patent/JP2010174050A/ja active Pending
- 2010-12-22 US US12/976,414 patent/US8709498B2/en not_active Expired - Lifetime
2013
- 2013-07-01 JP JP2013137996A patent/JP2013189477A/ja active Pending

Also Published As

Publication number	Publication date
JP2013189477A (ja)	2013-09-26
WO2002058692A9 (fr)	2003-03-06
CY1106704T1 (el)	2012-05-23
US8709498B2 (en)	2014-04-29
DE60219314T2 (de)	2008-01-03
CA2435419A1 (fr)	2002-08-01
FR2819723A1 (fr)	2002-07-26
AU2002231889A1 (en)	2002-08-06
EP1401422A2 (de)	2004-03-31
JP2010174050A (ja)	2010-08-12
DE60219314D1 (de)	2007-05-16
WO2002058692A2 (fr)	2002-08-01
CA2435419C (fr)	2012-06-05
EP1401422B1 (de)	2007-04-04
US20040022871A1 (en)	2004-02-05
US7879366B2 (en)	2011-02-01
ES2284837T3 (es)	2007-11-16
DK1401422T3 (da)	2007-08-06
JP2004519462A (ja)	2004-07-02
PT1401422E (pt)	2007-07-09
WO2002058692A3 (fr)	2003-12-24
US20090022815A1 (en)	2009-01-22
US20110091578A1 (en)	2011-04-21
FR2819723B1 (fr)	2006-11-17

Legal Events

Date

Code

Title

Description

2007-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1401422

Country of ref document: EP

Publication	Publication Date	Title
ATE358474T1 (de)	2007-04-15	Halogenhaltige zusammensetzung, verfahren zu deren herstellung und deren verwendung
DE69933208D1 (de)	2006-10-26	Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
DK1898876T3 (da)	2009-03-02	Mucoadhæsive xyloglucanholdige fprmuleringer anvendelige i medicinske anordninger og i farmaceutiske former
BR9406363A (pt)	1996-02-27	Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
BR0107565A (pt)	2003-02-11	Formas de dosagem de benzimidazol substituìdo e método de emprego das mesmas
ATE489956T1 (de)	2010-12-15	Formulierungen enthaltend salicylate und deren verwendung zur behandlung von entzündlicher darmerkrankung
BRPI0519195A2 (pt)	2008-12-30	composiÇço de cuidado oral, e, mÉtodo para prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal
CY1108932T1 (el)	2014-07-02	Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
NO20024646L (no)	2002-10-15	Kombinasjonsterapier med vaskul¶r-skadende aktivitet
CY1114133T1 (el)	2016-07-27	ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ γ-ΦΑΙΝΥΛ-Δ-ΛΑΚΤΑΜΕΣ ΚΑΙ ΧΡΗΣΕΙΣ ΠΟΥ ΣΧΕΤΙΖΟΝΤΑΙ ΠΡΟΣ ΑΥΤΕΣ
ES2192839T3 (es)	2003-10-16	Timosina beta 4 oxidada.
NO994431L (no)	1999-09-13	Ny formulering
TR200200716T2 (tr)	2002-06-21	Ketiyapin granülleri
BR0316458A (pt)	2005-10-11	Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
BR0313718A (pt)	2005-07-12	Composto, processo para a preparação do mesmo, composição farmacêutica, métodos para tratar um indivìduo humano ou animal sofrendo de uma condição que é mediada por cox-2 e para tratar um indivìduo humano ou animal sofrendo de um distúrbio inflamatório, e, uso de um composto
EA200001010A1 (ru)	2001-02-26	Применение дексмедетомидина для седативного воздействия в отделении интенсивной терапии
NO994165L (no)	1999-10-25	Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
BR0315462A (pt)	2005-08-23	Composto, composição farmacêutica, uso de um composto, método para o tratamento de um sujeito que sofre de uma condição patológica ou de doença susceptìvel de alìvio por antagonismo de receptores de ltd4 e produto de combinação
BRPI0409699A (pt)	2006-04-18	métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos
DK1194109T3 (da)	2004-10-25	Topiske formuleringer omfattende hud-gennemtrængningsmidler samt anvendelse deraf
MX9403032A (es)	1995-01-31	Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos.
BR9814867A (pt)	2000-10-03	Método para tratar discinesias relacionadas a doenças ou induzidas por drogas
RU94011321A (ru)	1996-01-20	Способ профилактики и лечения заболеваний кожи
AR039162A1 (es)	2005-02-09	Formulaciones de venlafaxina de liberacion extendida
CY1107346T1 (el)	2012-12-19	Φαρμακευτικη συνθεση για την ενδοκυτταρια οξινιση με cis-ουροκανικο οξυ